ArticleInternational journal of molecular sciences2022

An Ultra-Low Dose of ∆9-Tetrahydrocannabinol Alleviates Alzheimer's Disease-Related Cognitive Impairments and Modulates TrkB Receptor Expression in a 5XFAD Mouse Model.

Keren Nitzan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.